Crosstalk between triple negative breast cancer and microenvironment
PDF | Full Text | How to cite | Press Release
Metrics: PDF 271 views | Full Text 1447 views | ?
Karly Smrekar1, Artem Belyakov1 and Kideok Jin1
1 Department of Pharmaceutical Sciences, Albany College of Pharmacy and Health Science, Albany, NY 12208, USA
|Kideok Jin,||email:||[email protected]|
Keywords: triple negative breast cancer; tumor microenvironment; current therapy
Received: January 13, 2023 Accepted: March 21, 2023 Published: March 31, 2023
Although many advances have been made in the treatment of breast cancer, for the triple negative breast cancer (TNBC) these therapies have not significantly increased overall survival. Tumor microenvironment (TME) plays an essential role to develop and control TNBC progression. Many preclinical and clinical studies are ongoing to treat patients with TNBC disease, but the effective therapies are currently not available. Here, we have reviewed recent progress in understanding of TNBC and advance in defining mechanisms of TNBC therapies and potential therapeutic strategies to overcome TNBC.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.